Data Minimization: Balancing GDPR & Research Insights
Data minimization is one of the fundamental principles of the General Data Protection Regulation (GDPR), aimed at ensuring that...
Top 3 GDPR Compliance Questions in Clinical Trials
In the fast-evolving world of clinical trials, GDPR compliance is more than a legal obligation—it’s a pillar of trust,...
FDA Update on ICH E6, E8, QbD and RBM in Clinical Trials
The recent FDA workshop, “Building Quality into the Design and Conduct of Clinical Studies: Integrating Quality by Design (QbD)...
Dynamic Consent: A New GDPR Standard for Clinical Trials
In an era where data is the cornerstone of innovation, the concept of dynamic consent is emerging as a...
The Emergence of Superintelligence in Healthcare, Biotech, and Clinical Trials
The journey toward superintelligence unlocks extraordinary capabilities poised to revolutionize medicine and healthcare. These systems can process vast amounts...
How The Trump Administration Will Impact The Future of Clinical Trials and Biopharma
The re-election of Donald Trump in 2024 marks the start of a dramatic transformation in healthcare, biotech, and clinical...
GDPR Class Actions: Compliance now for Trial Sponsors
On December 1, 2024, the European non-profit organization noyb (None of Your Business), co-founded by privacy advocate Max Schrems,...
Privacy Now: Balancing Innovation and Privacy in Genomics
The UK’s Information Commissioner’s Office (ICO) recently issued a critical call for collaboration in genomics, emphasizing the need to...
How GDPR Drives Trust in Patient-Centric Trials
In recent years, patient-centric trial designs have emerged as a transformative approach in clinical research, placing patients at the...
Alzheimer’s Trials and Others See More Diversity When Technology and Humans Work Together
Clinical trial sponsors are facing mounting pressure to secure trial participants that more closely reflect the diverse populations affected...